John Niederhuber, the director of the National Cancer Institute, responds to the recent criticism on how cancer-related grants are doled out — the New York Times' Gina Kolata said that it leads to researchers avoiding risky projects that she thinks may have better payoffs.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.